Pulmonary hypertension (PH) is a disease diagnosed when arteries responsible for carrying blood become, thick, stiff and clogged. Normally, the arteries transport blood from the heart to the lungs, but in PH the vessel flow is hampered leading to abnormally high blood pressure in the pulmonary arteries. The disease results in excessive effort by the right heart ventricle to pump blood to the body, which causes it to expand and weaken. In severe cases, pulmonary hypertension can lead to the complete inability of the heart to pump blood to the lungs, right heart failure or death. All of these factors contribute to life expectancy among PH patients, without treatment, of 2.8 years on average. Fortunately, novel PH therapies are working to improve outcome.

The rare condition affects people of all ages, races and ethnicity, but it is more common among young adults and women. First signs of PH can be shortness of breath, difficulties to complete daily tasks like climbing stairs, fatigue and dizziness. Other symptoms associated with PH include fatigue, fainting, irregular heartbeat, racing pulse, progressive shortness of breath, difficulty breathing at rest, swollen ankles, abdomen or legs; bluish lips and skin; and chest pain. Most symptoms are usually only present in advanced stages of the disease.

Pulmonary Hypertension Life Expectancy: What To Expect After a PH Diagnosis

There is currently no cure for pulmonary hypertension. A progressive disease, it gets worse with time and if left untreated, patients with PH may die within few years.

Despite no cure for PH, treatments exist that can delay the disease progression. PH patients face a higher risk of heart failure and a decrease in overall health, but medication and lifestyle alterations can help increase life expectancy.

Though PH patients have 68% probability of surviving after the first year of diagnosis, and the chances decrease to 34% four years later, according Ohio State University Lung Center, early diagnosis is critical in increasing the pulmonary hypertension life expectancy.

First, to confirm the diagnosis, physicians usually conduct a complete medical history, physical examination, symptom evaluation and identification of abnormal heart sounds. They search for an engorgement of the jugular vein in the neck, seek to find fluid retention in the abdomen, legs or ankles, examine nail beds for bluish tint, and identify any underlying signs or causes of PH.

Additionall, other tests are completed that include blood tests, doppler echocardiogram, chest X-ray, a 6-minute walk test, pulmonary function tests, polysomnogram or overnight oximetry, right heart catheterization, ventilation perfusion scan (V/Q scan), pulmonary angiogram and chest CT scan to support the diagnosis.

Sometimes, conditions that contribute to the development of pulmonary hypertension cannot be fully understood; even when those factors influence PH prognosis and life expectancy.

Factors That Influence the Pulmonary Hypertension Life Expectancy

There are different types of pulmonary hypertension. including idiopathic pulmonary hypertension and associated pulmonary hypertension.

Idiopathic pulmonary hypertension is diagnosed when the cause for the disease is unknown.

Associated pulmonary hypertension is typically related to other factors such as lung disease, heart disease, hypoxia (low oxygen in the blood), clots, parasites, certain blood disorders, cirrhosis, AIDS, connective tissue diseases, weight reducing drugs and certain toxins.

Depending on the type of pulmonary hypertension, it is extremely important to carefully follow the associated disease so that it does not decrease overall health and lead to accelerated PH progression.

A study, “Factors that influence the outcome of primary pulmonary hypertension,” highlights that factors contributing to life expectancy in primary pulmonary hypertension have not been well defined.

In the study, researchers analyzed 34 PH cases and concluded that age at disease onset, symptoms, or sex of the patient could not predict pulmonary hypertension life expectancy. The study also demonstrated that while radiographic evidence of cardiac enlargement and evidence of right heart strain on electrocardiogram are predictable factors of survival, “primary pulmonary hypertension is a heterogeneous condition in which life expectancy varies widely.”

Note: Pulmonary Hypertension News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Find Out More